Private equity player Audax Group said yesterday it is looking to recapitalize fluid warming infusion systems provider Belmont Instruments, but did not say how much money it will invest in the company.
Billerica, Mass.-based Belmont produces rapid infusion systems designed to treat critically injured patients with material blood loss, according to Audax.
“Belmont is a best-in-class provider of life-sustaining fluid warming infusion systems. We are excited to partner with management to build on Belmont’s leading position and accelerate growth by continuing its investment in new product development, global marketing and salesforce expansion, and through acquisition of complementary patient warming and critical care medical technologies,” Audax co-CEO Geoffrey Rehnert said in a press release.
Audax Group said it has partnered with Belmont’s private owners as part of the recapitalization efforts.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.